@ARTICLE{
author={Cufer Tanja,Ciuleanu Tudor E,Berzinec Peter,Galffy Gabriela,Jakopovic Marko,Jassem Jacek,Jovanovic Dragana D,Mihaylova Zhasmina,Ostoros Gyula,Thallinger Christiane,Zemanova Milada,Zielinski Christoph},
year={2020},
title={Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis},
journal={ONCOLOGIST},
volume={25},
number={3},
pages={E598-E601},
document_type={Article},
} 

@ARTICLE{
author={Vrdoljak Eduard,Wojtukiewicz MZ,Pienkowski T,Bodoky G,Berzinec Peter,Finek J,Todorovic Vladimir,Borojevic Nenad D,Croitoru Adina},
year={2011},
title={Cancer epidemiology in Central and South Eastern European countries},
journal={CROATIAN MEDICAL JOURNAL},
volume={52},
number={4},
pages={478-487},
document_type={Editorial Material},
} 

@ARTICLE{
author={Vrdoljak Eduard,Wojtukiewicz MZ,Pienkowski T,Bodoky G,Berzinec Peter,Finek J,Beslija S,Todorovic Vladimir,Borojevic Nenad D,Yilmaz U},
year={2008},
title={Current Oncology Situation In Eastern and Southern European Countries: South Eastern European Research Oncology Group (Seerog) Initiative},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={225-225},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smit E,Reck M,Krzakowski M,Gridelli C,Curescu S,Berzinec Peter,Barata F,McDermott R,Jovanovic D,Magyarlo P},
year={2007},
title={Erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): interim results from the European subpopulation of the open-label TRUST study},
journal={EJC SUPPLEMENTS},
volume={5},
number={4},
pages={359-359},
document_type={Meeting Abstract},
}